Shares of Arena Pharmaceuticals jumped 4.61% to $69.82 at 15:05 EST on Tuesday, following yesterday's downward trend. The Nasdaq Stock Market is rising 0.59% to $12,593.20, after three sequential sessions in a row of gains, on what so far seems, a somewhat positive trend exchanging session today.
Arena Pharmaceuticals's last close was $66.75, 29.18% under its 52-week high of $90.19.
Arena Pharmaceuticals's Sales
Arena Pharmaceuticals's sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company's growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals's Stock Top and Bottom Yearly Value
Arena Pharmaceuticals's stock is valued at $69.82 at 15:05 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.